The functional characterization of ILEI to be a novel cytokine involved in epithelial/mesenchymal transition and the identification of biologically active ILEI provides the basis for generating ILEI inhibitors, in particular anti-ILEI antibodies, that are useful in the therapy of cancer, fibrosis and COPD.

 
Web www.patentalert.com

< Monomethylvaline compounds capable of conjugation to ligands

< Disalt inhibitors of IL-12 production

> Slotted screw for use with a vertebral member

> Methods for treating the spine

~ 00621